These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 2828228)
1. In vitro expansion of Epstein-Barr virus-specific HLA-restricted cytotoxic T cells direct from the blood of infectious mononucleosis patients. Strang G; Rickinson AB Immunology; 1987 Dec; 62(4):647-54. PubMed ID: 2828228 [TBL] [Abstract][Full Text] [Related]
2. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis. Strang G; Rickinson AB Eur J Immunol; 1987 Jul; 17(7):1007-13. PubMed ID: 2440688 [TBL] [Abstract][Full Text] [Related]
3. Recruitment during infectious mononucleosis of CD3+CD4+CD8+ virus-specific cytotoxic T cells which recognise Epstein-Barr virus lytic antigen BHRF1. White CA; Cross SM; Kurilla MG; Kerr BM; Schmidt C; Misko IS; Khanna R; Moss DJ Virology; 1996 May; 219(2):489-92. PubMed ID: 8638417 [TBL] [Abstract][Full Text] [Related]
4. Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis. Tomkinson BE; Maziarz R; Sullivan JL J Immunol; 1989 Jul; 143(2):660-70. PubMed ID: 2472449 [TBL] [Abstract][Full Text] [Related]
5. T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis. Klein E; Ernberg I; Masucci MG; Szigeti R; Wu YT; Masucci G; Svedmyr E Cancer Res; 1981 Nov; 41(11 Pt 1):4210-5. PubMed ID: 6272964 [TBL] [Abstract][Full Text] [Related]
6. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. III. Establishment of HLA-restricted cytotoxic T cell lines using interleukin 2. Wallace LE; Rowe M; Gaston JS; Rickinson AB; Epstein MA Eur J Immunol; 1982 Dec; 12(12):1012-8. PubMed ID: 6297919 [TBL] [Abstract][Full Text] [Related]
8. Absence of Epstein-Barr virus-specific, HLA class II-restricted CD4+ cytotoxic T lymphocytes in infectious mononucleosis. Enssle KH; Fleischer B Clin Exp Immunol; 1990 Mar; 79(3):409-15. PubMed ID: 1690617 [TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease. Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978 [TBL] [Abstract][Full Text] [Related]
10. B-cell polyclonal activation and Epstein-Barr viral abortive lytic cycle are two key features in acute infectious mononucleosis. Al Tabaa Y; Tuaillon E; Jeziorski E; Ouedraogo DE; Bolloré K; Rubbo PA; Foulongne V; Rodière M; Vendrell JP J Clin Virol; 2011 Sep; 52(1):33-7. PubMed ID: 21684200 [TBL] [Abstract][Full Text] [Related]
11. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells. Wasik M; Myc A; Matej H; Rudzka L Arch Immunol Ther Exp (Warsz); 1983; 31(6):871-8. PubMed ID: 6331340 [TBL] [Abstract][Full Text] [Related]
12. Sustained CD8+ T-cell immune response to a novel immunodominant HLA-B*0702-associated epitope derived from an Epstein-Barr virus helicase-primase-associated protein. Turcanová V; Höllsberg P J Med Virol; 2004 Apr; 72(4):635-45. PubMed ID: 14981767 [TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection. Sugaya N; Kimura H; Hara S; Hoshino Y; Kojima S; Morishima T; Tsurumi T; Kuzushima K J Infect Dis; 2004 Sep; 190(5):985-8. PubMed ID: 15295706 [TBL] [Abstract][Full Text] [Related]
14. Suppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosis. Wang F; Blaese RM; Zoon KC; Tosato G J Clin Invest; 1987 Jan; 79(1):7-14. PubMed ID: 3025263 [TBL] [Abstract][Full Text] [Related]
16. Human cytotoxic T lymphocytes. III. Large numbers of peripheral blood T cells clonally develop into allorestricted anti-viral cytotoxic T cell populations in vitro. Kabelitz D; Herzog WR; Heeg K; Wagner H; Reimann J J Mol Cell Immunol; 1987; 3(1):49-60. PubMed ID: 2855406 [TBL] [Abstract][Full Text] [Related]
17. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation. Nolte A; Buhmann R; Straka C; Emmerich B; Hallek M Bone Marrow Transplant; 1998 May; 21(9):909-16. PubMed ID: 9613783 [TBL] [Abstract][Full Text] [Related]
18. Memory of Epstein-Barr virus-specific cytotoxic T cells in normal seropostive adults as revealed by an in vitro restimulation method. Tanaka Y; Sugamura K; Hinuma Y; Sato H; Okochi K J Immunol; 1980 Oct; 125(4):1426-31. PubMed ID: 6157733 [TBL] [Abstract][Full Text] [Related]
19. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis). Tosato G; Straus S; Henle W; Pike SE; Blaese RM J Immunol; 1985 May; 134(5):3082-8. PubMed ID: 2984282 [TBL] [Abstract][Full Text] [Related]